FDA recommends health care professionals discuss naloxone with all patients when prescribing opioid pain relievers or medicines to treat opioid use disorder (OUD)

The FDA is requiring new recommendations about naloxone to be added to the prescribing information for all opioids and medicines to treat OUD in the US, to help ensure health care professionals discuss its availability and assess each patient’s need for a prescription.


US Food and Drug Administration